TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Panafarma Medical Consult AB
Closing information (x1000 DKK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
189
|
267
|
253 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
33
|
22
|
1 |
| EBITDA |
33
|
22
|
3 |
| Total assets |
232
|
318
|
339 |
| Current assets |
231
|
317
|
338 |
| Current liabilities |
75
|
139
|
126 |
| Equity capital |
147
|
169
|
196 |
| - share capital |
63
|
70
|
73 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
63.4%
|
53.1%
|
57.8% |
| Turnover per employee |
94
|
134
|
126 |
| Profit as a percentage of turnover |
17.5%
|
8.2%
|
0.4% |
| Return on assets (ROA) |
14.2%
|
7.2%
|
0.6% |
| Current ratio |
308.0%
|
228.1%
|
268.3% |
| Return on equity (ROE) |
22.4%
|
13.0%
|
0.5% |
| Change turnover |
-52
|
26
|
-96 |
| Change turnover % |
-22%
|
11%
|
-28% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.